HOME
SEARCH
RSS FEED
SUBSCRIBE
Fibroblast Growth Factor 3 (FGFR3) Receptor Knockin Mice
Case ID:
TAB-686
Web Published:
12/6/2022
Description:
Missense mutations in Fibroblast Growth Factor Receptor 3 (FGFR3) result in several human skeletal dysplasias, including the most common form of dwarfism, achondroplasia.
The NIH announces the generation of FGFR3 knockin mice, which have a Gly369Cys mutation, inserted into the mouse genome. Phenotypic analysis of the mice reveals that the FGF/FGFR3 signals affect both chondrogenesis and osteogenesis by regulating Stat proteins and cell-cycle inhibitors, and the activities of chondrocytes, osteoclasts, and osteoblasts during endochondral ossification. These mice provide a new animal model to study functions of FGF/FGFR3 signals in achondroplasia patients, which could lead to new drug discovery and therapeutic treatments.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/Fibroblast_Growth_Factor_3_(FGFR3)_R eceptor_Knockin_Mice
Category(s):
Licensing
Research Materials
Bookmark this page
Download as PDF
For Information, Contact:
Inteum Admin
NIH Technology Transfer
Inventors:
Chuxia Deng
Keywords:
Achondroplasia
Dwarfism
RXXXXX
Skeletal dysplasias
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum